Navigation Links
Meso Foundation Participates in Prestigious Conference on Lung Cancer
Date:10/26/2013

Washington, DC (PRWEB) October 26, 2013

On October 27 – 30, Mary Hesdorffer, Nurse Practitioner and executive director of the Mesothelioma Applied Research Foundation (Meso Foundation), and Melinda Kotzian, the chief executive officer of the Meso Foundation, are scheduled to attend and participate in the 15th World Conference on Lung Cancer in Sydney, Australia, organized by the International Association for the Study of Lung Cancer (IASLC).

They will be representing the Mesothelioma Applied Research Foundation and will be raising awareness of mesothelioma amidst over 7,000 delegates from over 100 countries.

In her capacity as an expert in mesothelioma treatment and care, Ms. Hesdorffer is scheduled to speak at several sessions, including one on the use of social media networks to communicate with and provide support to mesothelioma patients. Ms. Hesdorffer is a pioneer in this area. As a speaker, Ms. Hesdorffer’s travel and lodging costs are entirely covered by IASLC.

Ms. Kotzian’s travel costs are also covered through a grant by IASLC for which she applied earlier this year. She was one of five grant recipients from nonprofit organizations from all over the world awarded travel grants to enable them to attend this event.

"I am very grateful to IASLC for this grant," said Ms. Kotzian. "Being able to attend this important conference will allow me to represent the Foundation at a global level, thus helping advance the organization's mission of developing effective treatments and, ultimately, curing mesothelioma," she added.

The Meso Foundation will also be hosting a booth with information about mesothelioma and programs and services provided by the Foundation.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. Approximately 3,500 Americans are diagnosed with mesothelioma every year and an estimated one-third were exposed in Navy ships or shipyards.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)3 non-profit organization dedicated to eradicating mesothelioma and easing the suffering caused by it. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish more effective treatments for mesothelioma and, ultimately, a cure for this rare, but extremely aggressive, cancer. To date, the Foundation has awarded over $8.2 million to research.

More information is available at http://www.curemeso.org.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11271747.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Junqian (Gordon) Xu, PhD, Awarded $150,000 Grant from Radiological Society of North American Research and Education Foundation
2. According to the United Health Foundation, The Burden of Diabetes in Missouri is on the Rise, Affecting Over Ten Percent of Residents
3. Sensory Processing Disorder Foundation Celebrates National Sensory Awareness Month
4. Miracle-Ear Foundation Gives the Gift of Sound to First Adult Recipient
5. Gates Foundation and Mayo Clinic Experts to Address Vaccine Research in the 21st Century
6. Kevin Nealon to Host Second Annual Celebrity Golf Classic to Benefit Melanoma Research Foundation November 18th
7. Delray Recovery Center Presenting the Brandi’s Wish Foundation’s 3rd Annual Weekend Tennis Event
8. Colleen’s Dream Foundation Gifts $10,000 to The University of Texas MD Anderson Cancer Center to Support Ovarian Cancer Research
9. International Essential Tremor Foundation to Facilitate Educational Seminar in Suffern, N.Y.
10. National Science Foundation BRAIN Workshop Report e-Published on IEEE Transactions on Biomedical Engineering
11. Migraine Research Foundation Hits Hole-in-One With Golf Outing and Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: